Simplifying Global Compliance
Medtronic Neuro Gets Warning Letter, FDA Wants to Meet on Motor Flaws
Devices & Diagnostics Letter
Medtronic’s neuromodulation unit has received an FDA warning letter on allegations the business segment did not handle complaints properly, among other corrective and preventive action (CAPA) violations.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing